Examination of Trends in Colorectal Cancer Patients' Clinical Study Experiences

NCT05891730 | Unknown

• 1 other identifier: 82251637
• Study Type: observational
• Target: 500
• Locations: 1 country
• Sites: 1

Brief Summary

Clinical study participation percentages haven't always been fully representative of a given demographic. Participation in this observational clinical research is extremely valuable since it allows people with colorectal cancer to contribute their own experiences and unique viewpoints. These vital contributions have the potential to affect the development of novel therapies and support services dramatically. Trial's findings will be critical in furthering the understanding of colorectal cancer, ultimately leading to better patient outcomes.

Conditions

Colorectal Cancer

Keywords

colorectal cancer

Outcome Measures

Primary Outcomes (2)

• Rate of patients who decide to enroll in a colorectal cancer clinical study.

  3 months

• Number of colorectal cancer patients who remain in clinical trial until completion.

  12 months

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Colorectal cancer patients who are actively considering involvement in an observational clinical study, but have not yet completed enrollment and registration.

You may qualify if:

• Participant has a diagnosis of colorectal cancer
• Patient has self-identified as planning to enroll in a clinical trial for colorectal cancer
• Patient is at least 18 years of age

You may not qualify if:

• Inability to perform regular electronic reporting
• Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial
• Pregnant or lactating woman

Sponsors & Collaborators

• Power Life Sciences Inc.: lead

Study Sites (1)

Power Life Sciences

San Francisco, California, 94107, United States

Location

Related Publications (3)

• Winkels RM, Heine-Broring RC, van Zutphen M, van Harten-Gerritsen S, Kok DE, van Duijnhoven FJ, Kampman E. The COLON study: Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of life. BMC Cancer. 2014 May 27;14:374. doi: 10.1186/1471-2407-14-374.

  PMID: 24886284 BACKGROUND

• Veettil SK, Wong TY, Loo YS, Playdon MC, Lai NM, Giovannucci EL, Chaiyakunapruk N. Role of Diet in Colorectal Cancer Incidence: Umbrella Review of Meta-analyses of Prospective Observational Studies. JAMA Netw Open. 2021 Feb 1;4(2):e2037341. doi: 10.1001/jamanetworkopen.2020.37341.

  PMID: 33591366 BACKGROUND

• Njor SH, Andersen B, Friis-Hansen L, de Haas N, Linnemann D, Norgaard H, Roikjaer O, Sondergaard B, Rasmussen M. The optimal cut-off value in fit-based colorectal cancer screening: An observational study. Cancer Med. 2021 Mar;10(5):1872-1879. doi: 10.1002/cam4.3761. Epub 2021 Feb 3.

  PMID: 33534955 BACKGROUND

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases

Study Officials

• Michael B Gill

  Power Life Sciences Inc.

  STUDY DIRECTOR

Central Study Contacts

Michael B Gill

CONTACT

415-900-4227; bask@withpower.com

Study Design

• Study Type: observational
• Observational Model: CASE CROSSOVER
• Time Perspective: PROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 26, 2023
• First Posted: June 7, 2023
• Study Start: June 1, 2024
• Primary Completion: June 1, 2024
• Study Completion: June 1, 2024
• Last Updated: June 7, 2023

Record last verified: 2023-05

Locations

US (1)